14 results
·
25ms
·
Sources: EU EUDAMED, US FDA
AMS OPTILUME INFLATION SYRINGE
FDA 510(k)
FDA Class 2
·Gastroenterology, Urology
Keystone Industries
FDA UDI
Keystone Industries·H66819007601·Pkg/10x1 Ft Clasp Wire 17Ga Rd
BONE MULCH TRAY
FDA UDI
Biomet Orthopedics, LLC·00880304479944·
3D
FDA UDI
Rmo, Inc.·00885797100153·3D LING ARCH ASST 30
CooperSurgical, Inc.
FDA UDI
Coopersurgical, Inc.·00888937003680·1X Macro Bipolar Insert
THERATEST EL-ANTI-TPO AND THERATEST EL-ANTI-THYROGLOBULIN, MODEL 104-119, 103-120
FDA 510(k)
FDA Class 2
·Immunology
REACH FEMORAL COMPONENT
FDA 510(k)
FDA Class 2
·Orthopedic
SODIUM CHLORIDE INHALATION SOLUTION 3%
FDA Adverse Event
NEPHRON SC, INC.·Product code CAF·December 3, 2021
EVOLUT R TRANSCATHETER AORTIC VALVE
FDA Adverse Event
Injury
·MEDTRONIC HEART VALVES DIVISION·Product code NPT·September 1, 2021
G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM
FDA Adverse Event
Malfunction
·DEXCOM, INC.·Product code MDS·June 27, 2014
UNICEL® DXI 600 ACCESS® IMMUNOASSAY ANALYZER
FDA Adverse Event
Malfunction
·BECKMAN COULTER, INC.·Product code JJE·November 16, 2010
DA VINCI S
FDA Adverse Event
Malfunction
·INTUITIVE SURGICAL·Product code NAY·January 3, 2013
Sodium Chloride Inhalation Solution, USP 7%, 60 x 4 mL Sterile Unit-Dose Vials, Rx Only, NDC 0487-9007-60. A vial contains sterile, preservation-free, clear, colorless, aqueous solution as labeled for induction of sputum production where specimen collection is indicated. For respiratory therapy, Solium Chloride Inhalation Solution USP, 3% is used in conjunction with a nebulizer
FDA Enforcement
Class II
·Terminated·Nephron Pharmaceuticals Corp.·July 6, 2016
Sodium Chloride Inhalation Solution, USP 7%, 60 x 4 mL Sterile Unit-Dose Vials, Rx Only, NDC 0487-9007-60. A vial contains sterile, preservation-free, clear, colorless, aqueous solution as labeled for induction of sputum production where specimen collection is indicated. For respiratory therapy, Solium Chloride Inhalation Solution USP, 3% is used in conjunction with a nebulizer
FDA Recall
Terminated
·Nephron Pharmaceuticals Corp.·Product code CAF·November 16, 2015